To solve the puzzle of whether supplementation with ACE inhibitors can benefit patients with Alzheimer’s disease and/or dementia, additional insights into ACE inhibitor-mediated gene regulation are indispensable. Here, ACE is linked to early-onset autosomal dominant Alzheimer disease.